Candriam SCA’s Aprea Therapeutics APRE Stock Holding History

Candriam SCA’s Portfolio APRE Stock Details APRE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell
2021 Q1	$1.71M	Sell
2020 Q4	$1.78M	Buy
2020 Q3	$5.63M	Buy
2020 Q2	$5.07M	Buy